Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study

被引:0
|
作者
Caminiti, Caterina [1 ]
Maglietta, Giuseppe [1 ]
Arenare, Laura [2 ]
Di Liello, Raimondo [3 ]
Migliaccio, Gessica [4 ]
Barberio, Daniela [4 ]
De Laurentiis, Michelino [5 ]
Di Rella, Francesca [5 ]
Nuzzo, Francesco [5 ]
Pacilio, Carmen [5 ]
Iodice, Giovanni [5 ]
Orditura, Michele [6 ,19 ]
Ciardiello, Fortunato [6 ]
Di Bella, Sara [7 ]
Cavanna, Luigi [8 ,20 ]
Porta, Camillo [9 ,10 ]
Giovanardi, Filippo [11 ]
Ripamonti, Carla Ida [12 ,21 ]
Bilancia, Domenico [13 ]
Aprile, Giuseppe [14 ]
Ruelle, Tommaso [15 ,16 ]
Diodati, Francesca [1 ]
Piccirillo, Maria Carmela [2 ]
Iannelli, Elisabetta [17 ]
Pinto, Carmine [18 ]
Perrone, Francesco [2 ]
机构
[1] Univ Hosp, Clin & Epidemiol Res Unit, Parma, Italy
[2] IRCCS Fdn G Pascale, Clin Trial Unit, Ist Nazl Tumori, Naples, Italy
[3] Osped Mare, Div Med Oncol, Naples, Italy
[4] IRCCS, Fdn G Pascale, Ist Nazl Tumori, Dept Struct Clin Psychooncol, Naples, Italy
[5] IRCCS Fdn G Pascale, Ist Nazl Tumori, Expt & Clin Senol Oncol Unit, Naples, Italy
[6] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy
[7] ASST Rhodense, Med Oncol, Rho, MI, Italy
[8] Osped Guglielmo Saliceto, Med Oncol, Piacenza, Italy
[9] Univ A Moro, Interdisciplinary Dept Med, Bari, Italy
[10] Polyclin Consortium Univ Hosp, Bari, Italy
[11] Osped Civile, Med Oncol, Guastalla, RE, Italy
[12] IRCCS, Ist Nazl Tumori, Support Care Unit, Milan, Italy
[13] Osped S Carlo, Med Oncol, Potenza, Italy
[14] Osped S Bortolo, Med Oncol, Azienda ULSS 8 Nerica, Vicenza, Italy
[15] IRCCS Osped Policlin San Martino, Med Oncol, Genoa, Italy
[16] Univ Genoa, Dept Internal Med & Med Specialties, DIMi, Genoa, Italy
[17] FAVO Federaz Italiana Assoc Volontariato Oncol, Rome, Italy
[18] AUSL IRCCS, Med Oncol, Reggio Emilia, Italy
[19] Osped Civile, Div Med Oncol, Caserta, Italy
[20] Casa Cura Piacenza, Internal Med & Oncol Unit, Piacenza, Italy
[21] Univ Brescia, Brescia, Italy
来源
BREAST | 2024年 / 77卷
关键词
Patient-reported outcome measures (PROMs); Electronic PROMs (ePROMs); PRO-CTCAE; HADS; EORTC BR-23; Convergent validity; Responsiveness; Breast cancer; VALIDITY; VERSION;
D O I
10.1016/j.breast.2024.103781
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients' self-reporting is increasingly considered essential to measure quality-of-life and treatment-related side- effects. However, if multiple patient-reported instruments are used, redundancy may represent an overload for patients. Patient-Reported Outcomes Common Terminology Criteria for Adverse Events (PRO-CTCAE) are a tool allowing direct patients' reporting of side-effects. We tested psychometric properties of a selected list of PRO-CTCAE items, in a cohort of 303 breast cancer patients, using validated instruments for quality of life assessment as anchors. The analysis of convergent validity with HADS (Hospital Anxiety and Depression Scale) and EORTC BR-23 sub- scales, and the analysis of responsiveness with the PGIC (Patients Global Impression of Change) score supported that a selected list of PRO-CTCAE symptoms might represent a standardized, agile tool for both research and practice settings to reduce patient burden without missing relevant information on patient perceptions. Among patients using digital devices, those with a higher education levels required shorter time to fulfil questionnaires. In conclusion, a selected list of PRO-CTCAE items can be considered as a standardized, agile tool for capturing crucial domains of side-effects and quality of life in patients with breast cancer. The study is registered on clinicaltrials.gov (NCT04416672).
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Validation study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Dueck, A. C.
    Mendoza, T. R.
    Reeve, B. B.
    Sloan, J. A.
    Cleeland, C. S.
    Hay, J.
    Li, Y.
    O'Mara, A. M.
    Denicoff, A.
    Basch, E. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Psychometric validity of the Japanese version of Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Azuma, Kanako
    Kawaguchi, Takashi
    Miyaji, Tempei
    Sano, Motohiko
    Kim, Soan
    Kawahara, Yosuke
    Torii, Ayako
    Yamada, Yuri
    Hirata, Taiki
    Ishibashi, Keiichiro
    Okubo, Atsushi
    Basch, Ethan
    Yamaguchi, Takuhiro
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 100 - 101
  • [3] Psychometric evaluation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (Pediatric PRO-CTCAE)
    Reeve, Bryce
    McFatrich, Molly
    Lin, Li
    Lucas, Nicole
    Castellino, Sharon
    Withycombe, Janice
    Jacobs, Shana
    Mack, Jennifer
    Freyer, David
    Baker, Justin
    Maurer, Scott
    Josephs, Isabel
    Pinheiro, Laura
    Petrany, Mary
    Dibridge, Sharon
    Sung, Lillian
    Hinds, Pamela
    QUALITY OF LIFE RESEARCH, 2019, 28 : S20 - S21
  • [4] DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)
    Basch, E.
    Reeve, B.
    Cleeland, C.
    Sloan, J.
    Schrag, D.
    Atkinson, T. M.
    Mendoza, T.
    Hay, J.
    Abernethy, A.
    Minasian, L.
    Kwitkowski, V
    Trentacosti, A. M.
    Burke, L.
    Sit, L.
    Bruner, D.
    VALUE IN HEALTH, 2010, 13 (07) : A274 - A275
  • [5] DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS ( PRO-CTCAE)
    Basch, E.
    Reeve, B.
    Cleeland, C.
    Sloan, J.
    Mendoza, T.
    Abernethy, A.
    Bruner, D.
    Hay, J.
    Atkinson, T.
    Sit, L.
    Minasian, L.
    O'Mara, A.
    Burke, L.
    Schrag, D.
    VALUE IN HEALTH, 2010, 13 (03) : A44 - A44
  • [6] Development of the Patient-Reported Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Basch, Ethan
    Reeve, Bryce
    Cleeland, Charles S.
    Sloan, Jeff A.
    Schrag, Deborah
    Atkinson, Thomas M.
    Mendoza, Tito R.
    Hay, Jennifer L.
    Abernethy, Amy P.
    Minasian, Lori
    Kwitkowski, Virginia
    Trentacosti, Ann Marie
    Burke, Laurie
    Sit, Laura
    Bruner, Deborah W.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 50 - 51
  • [7] Development of the patient-reported version of the common terminology criteria for adverse events (PRO-CTCAE)
    Basch, E. M.
    Reeve, B. B.
    Cleeland, C. S.
    Sloan, J. A.
    Mendoza, T. R.
    Abemethy, A. P.
    Bruner, D.
    Minasian, L. M.
    Burke, L. B.
    Schrag, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
    Hagelstein, V.
    Ortland, I.
    Wilmer, A.
    Mitchell, S. A.
    Jaehde, U.
    ANNALS OF ONCOLOGY, 2016, 27 (12) : 2294 - 2299
  • [9] Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Dueck, Amylou C.
    Mendoza, Tito R.
    Mitchell, Sandra A.
    Reeve, Bryce B.
    Castro, Kathleen M.
    Denicoff, Andrea
    O'Mara, Ann M.
    Rogak, Lauren J.
    Clauser, Steven B.
    Bryant, Donna M.
    Gillis, Theresa A.
    Bearden, James D.
    Siegel, Robert D.
    Harness, Jay K.
    Paul, Diane B.
    Cleeland, Charles S.
    Sloan, Jeff A.
    Schrag, Deborah
    Minasian, Lori M.
    Basch, Ethan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC)
    Nichols, Christine
    Mitchell, Sandra A.
    Lang, Kathy
    Federico, Victoria
    Castro, Kathleen M.
    Rogak, Lauren J.
    Lalla, Deepa
    Clauser, Steven B.
    Reeve, Bryce B.
    Denicoff, Andrea
    Chen, Alice P.
    Piekarz, Richard
    Atkinson, Thomas Michael
    Mayer, Musa
    Brammer, Melissa G.
    Sit, Laura
    O'Mara, Ann M.
    Minasian, Lori M.
    Basch, Ethan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)